Alexandria Ellen Melendez-Zaidi

Alexandria Ellen Melendez-Zaidi

Auto-generated profile, based on publicly available information

Alexandria Ellen Melendez-Zaidi

Division of Neurology, Department of Pediatrics Texas Children's Hospital and Baylor College of Medicine Houston Texas USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2017 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
ATAsami Tanimura
Asami Tanimura
TPTristano Pancani
Tristano Pancani
SLSean Austin O. Lim
Sean Austin O. Lim
CTCecilia Tubert
Cecilia Tubert
AMAlexandra E. Melendez
Alexandra E. Melendez
D. James SurmeierD. James Surmeier
D. James Surmeier

9 April 2018 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
RGRuoqi Gao
Ruoqi Gao
NPNicolas H. Piguel
Nicolas H. Piguel
AMAlexandria E. Melendez-Zaidi
Alexandria E. Melendez-Zaidi
MMM. Dolores Martin-de-Saavedra
M. Dolores Martin-de-Saavedra
SYSehyoun Yoon
Sehyoun Yoon
PPPeter Penzes
Peter Penzes

1 November 2015 in Cell Reports
Verified
Journal Article
Open access
IRIgor V. Rafalovich
Igor V. Rafalovich
AMAlexandria E. Melendez
Alexandria E. Melendez
JPJoshua L. Plotkin
Joshua L. Plotkin
ATAsami Tanimura
Asami Tanimura
SZShenyu Zhai
Shenyu Zhai
D. James SurmeierD. James Surmeier
D. James Surmeier
Experience-driven plasticity of glutamatergic synapses on striatal spiny projection neurons (SPNs) is thought to be essential to goal-directed behavior and habit formation. One major form of striatal plasticity, long-term depression (LTD), has long appeared to be expressed only pre-synaptically. Contrary to this view, nitric oxide (NO) generated by striatal interneurons was found to induce a post-synaptically expressed form of LTD at SPN glutamatergic synapses. This form of LTD was dependent on signaling through guanylyl cyclase and protein kinase G, both of which are abundantly expressed by SPNs. NO-LTD was unaffected by local synaptic activity or antagonism of endocannabinoid (eCb) and dopamine receptors, all of which modulate canonical, pre-synaptic LTD. Moreover, NO signaling disrupted induction of this canonical LTD by inhibiting dendritic Ca(2+) channels regulating eCb synthesis. These results establish an interneuron-dependent, heterosynaptic form of post-synaptic LTD that could act to promote stability of the striatal network during learning.

24 April 2019 in eLife
Verified
Journal Article
Open access
LCLuis Carrillo-Reid
Luis Carrillo-Reid
MDMichelle Day
Michelle Day
ZXZhong Xie
Zhong Xie
AMAlexandria E Melendez
Alexandria E Melendez
JKJyothisri Kondapalli
Jyothisri Kondapalli
D. James SurmeierD. James Surmeier
D. James Surmeier
Huntington’s disease (HD) is initially characterized by an inability to suppress unwanted movements, a deficit attributable to impaired synaptic activation of striatal indirect pathway spiny projection neurons (iSPNs). To better understand the mechanisms underlying this deficit, striatal neurons in ex vivo brain slices from mouse genetic models of HD were studied using electrophysiological, optical and biochemical approaches. Distal dendrites of iSPNs from symptomatic HD mice were hypoexcitable, a change that was attributable to increased association of dendritic Kv4 potassium channels with auxiliary KChIP subunits. This association was negatively modulated by TrkB receptor signaling. Dendritic excitability of HD iSPNs was rescued by knocking-down expression of Kv4 channels, by disrupting KChIP binding, by restoring TrkB receptor signaling or by lowering mutant-Htt (mHtt) levels with a zinc finger protein. Collectively, these studies demonstrate that mHtt induces reversible alterations in the dendritic excitability of iSPNs that could contribute to the motor symptoms of HD.

24 July 2019 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
AMAlexandria E. Melendez‐Zaidi
Alexandria E. Melendez‐Zaidi
HLHarini Lakshminarasimhah
Harini Lakshminarasimhah
D. James SurmeierD. James Surmeier
D. James Surmeier

18 January 2025 in Epilepsia
Verified
Journal Article
Open access
PEPoul H. Espino
Poul H. Espino
KEKrista Eschbach
Krista Eschbach
LBLeah J. Blank
Leah J. Blank
MCMackenzie Cervenka
Mackenzie Cervenka
EMEyal Muscal
Eyal Muscal
TGTeneille E. Gofton
Teneille E. Gofton
We propose and prioritize important outcome domains that should be considered for future research investigating long‐term outcomes (LTO) after new onset refractory status epilepticus (NORSE). The study was led by the international NORSE Institute LTO Working Group. First, literature describing the LTO of NORSE survivors was identified using a PubMed search and summarized to identify knowledge gaps. Subsequently, a consensus‐building process was performed to prioritize and rank important LTO domains for further research. The prioritization of LTO domains was qualitative, enabling the expert panel to generate ideas, share opinions, and provide reasons for the rankings. A second round took place to allow expansion and agreement regarding specific details for each domain. Outcomes were classified into eight main domains: (1) Function: Neuropsychological, Neurological (other than seizures), and Psychiatric (mood and behavior); (2) Quality of Life; (3) Epilepsy; (4) Nonneurological (medical); (5) Social; (6) Caregiver Burden; (7) Long‐Term Mortality; and (8) Health Care System Impact. In addition, the working group suggested obtaining outcome measures for each domain at 6 months and 1 year after discharge and annually thereafter until stability has been reached. There are no currently established time frames set for when LTO in NORSE begin or plateau, and previously there existed no consensus regarding which LTO should be considered. This consensus process identifies and recommends NORSE LTO domains that should be considered in future research studies to provide more consistent results that can be compared between studies. Survivors of NORSE should be evaluated serially and at fixed points over time to maximize our understanding of the recovery trajectory for all LTO domains. Establishing reliable and standardized data describing LTO (beyond seizures) after NORSE will support discussions with families during the acute stages, prognostication, the development of targeted management strategies for survivors, and future comparative research globally helping to identify biomarkers that may predict LTO.